 |
 |
 |
| Efficacité de la prévention en matière de coûts et traitement du pied diabétique |
| MONICA MARIA ORTEGON, WILLIAM KEN REDEKOP, LOUIS WILHELMUS NIESSEN |
| - Netherlands Institute of Health Sciences, Erasmus University, Rotterdam |
| - Institute for Medical Technology Assessment, Erasmus University, Rotterdam |
Diabetes is becoming one of the most common chronic diseases in the Netherlands. An age-related increase in the prevalence of diabetes of 32– 36% is estimated for the period from 1995 to 2010, at the end of which 400,000–500,000 cases are expected. |
Read full article |
|
 |
 |
| The Economic Costs of Undiagnosed Diabetes |
| Yiduo Zhang, Ph.D.,Timothy M. Dall, M.S.,Sarah E. Mann, B.S.,Yaozhu Chen, M.P.A.,
Jaana Martin, B.A.,Victoria Moore, B.S.,Alan Baldwin, M.A.,Viviana A. Reidel, M.D., William W. Quick, M.D., F.A.C.P., F.A.C.E. |
| - The Lewin Group, Falls Church, Virginia |
| - Ingenix=i3 Pharmainformatics, Cary, North Carolina |
| - Ingenix=i3 Research, Basking Ridge, New Jersey |
ne-fourth of the approximately 23.6 million people with diabetes in the United States are unaware they have the disease. While much is known about the population with diagnosed diabetes mellitus (DDM), data limitations have contributed to a paucity of information on the health care use patterns and economic burden associated with undiagnosed diabetes mellitus (UDM)— defined as unknowingly having an elevated glucose level that meets the definition of diabetes. |
Read full article |
|
 |
 |
| Variability in Activity May Precede
Diabetic Foot Ulceration |
| DAVID G. ARMSTRONG, CHRISTOPHER S. WENDEL, LAWRENCE A. LAVERY, BRENT P. NIXON, KATHERINE HOLTZ-NEIDERER, ANDREW J.M. BOULTON, MARTHA J. MOHLER |
| - Rosalind Franklin University of Medicine
and Science, Chicago, Illinois |
- Department of Surgery, Southern Arizona Veterans Affairs Medical Center,Tucson,
Arizona |
| - Department of Surgery, Texas A&M University, Temple, Texas |
| - 4Department of Medicine, Manchester Royal Infirmary, University of Manchester, U.K |
Diabetic foot ulcers and related maladies continue to be among the most common serious diabetesrelated sequelae, affecting some 68 per 1,000 individuals with diabetes per annum in the U.S. The pathologic process leading to the vast majority of foot ulcerations is a consistent one. In the face of neuropathy, pressure multiplied by repetitive moderate stress leads to inflammation and subsequent autolysis of soft tissue overlying bony prominences |
Read full article |
|
 |
 |
| Home Monitoring of Foot Skin
Temperatures to Prevent Ulceration |
| LAWRENCE A. LAVERY, RUBEN G. ZAMORANO, KEVIN R. HIGGINS, DAVID G. ARMSTRONG, DAN R. LANCTOT, KYRIACOS A. ATHANASIOU, GEORGE P. CONSTANTINIDES, C. MAULI AGRAWAL |
- College of Medicine, TexasA&MHealth Science Center, Scott and White
Hospital, Temple, Texas |
| - Xilas Medical, San Antonio, Texas |
- Dr. William M. Scholl College of Podiatric Medicine, Rosalind
Franklin University
of Medicine, Chicago, Illinois |
| - Department of Bioengineering, Rice University,
Houston, Texas |
- Department of Biomedical Engineering, The University of Texas, San Antonio,
Texas |
Foot ulcers are one of the most common precursors to diabetes-related amputations. Other factors that have been associated with amputation, such as infection, faulty wound healing, and ischemia, usually do not cause tissue loss or amputation in the absence of a wound. Therefore, ulcer prevention is one of the foci of any amputation prevention program. |
Read full article |
|
 |
 |
| Hypertension in people with Type 2 diabetes |
The International Diabetes Federation (Europe) has updated these guidelines on hypertension management specifically in Type 2 diabetes in the light of recent results of the first prospective, randomized controlled studies to investigate clinical outcomes in people with diabetes and hypertension. The guidelines are knowledge based, i.e. based not only on evidence originating from clinical trials, but also from epidemiological and pathophysiological studies. A successful management strategy requires the following components: 1. Regular surveillance to detect developing hypertension and other cardiovascular (CV) risk factors... |
Read full article |
|
 |
|
 |
*PDF veya SWF formatında sağlanan dosyaları görüntülemek için yazılım, Adobe Web sitesinden herhangi bir ücret ödenmeksizin temin edilebilir.
Get Adobe Reader Get Adobe Flash Player |